Medivate Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

Medivate Partners’ most common sector for investment islife science (100%). The Firm’s most common investment types include growth capital (67%) and buyout (lbo, mbo, mbi) (34%). In total, Medivate Partners has invested in 2 US states and 2 different countries.

In the last 3 years, Medivate Partners has exited 2 companies. The Firm’s most common exit type is trade sale (100%). Medivate Partners’ largest (disclosed) exit occurred in 2021 when it sold Cognate BioServices for $875M.

Join Mergr to view Medivate Partners’ full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity3
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 4

Medivate Partners

15F, Kwangil Plaza, 331,Gangnam-daero, Seocho-gu,
Seoul, 06627
South Korea
+82-2-536-0705
www.medivatepartners.com
info@medivatepartners.com

Medivate Partners is a private equity and venture capital firm focused on investment in the biotech/healthcare industry. The Firm looks will consider companies throughout Asia and North America and has a particular interest in businesses that can capitalize on cross border opportunities. Medivate Partners was established in 2012 and is headquartered in Seoul.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, Asia/Pacific

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
Sell (0.4/yr) # - - 2 - - - 2
vol $875M $875M
  5

Most Recent M&A

Company Date Value Type
WCCT Global LLC 2021-02-19 - Trade Sale
Cypress, California · www.wcct.com
Cognate BioServices, Inc. 2021-02-17 875M USD Trade Sale
Memphis, Tennessee · www.cognatebioservices.com
Cognate BioServices, Inc. 2018-02-20 - Buyout (LBO, MBO, MBI)
Memphis, Tennessee · www.cognatebioservices.com
SillaJen Biotherapeutics 2016-03-21 - Growth Capital
Busan, South Korea · www.sillajen.com
WCCT Global LLC 2015-06-26 - Growth Capital
Cypress, California · www.wcct.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 1 (100%) - 3 (100%) -
Total 1 - 3 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States - - 2 (67%) -
  Tennessee - - 1 (33%) -
  California - - 1 (33%) -
South Korea 1 (100%) - 1 (33%) -
Total 1 - 3 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 1 (100%) - 2 (67%) -
Buyout (LBO, MBO, MBI) - - 1 (33%) -
Total 1 - 3 -

Exits by Deal Type

Type Total # Value
Trade Sale 2 (100%) 875M (100%)
Total 2 $875M

Deal Values

sell # Total
$100M to $1B 1 $875M
TOTAL $875M
Largest Cognate BioServices, Inc.
$875M (2021-02-17)

M&A Connections

Deals
Exited to
Strategic(s)
100%
2 (100%)

FAQ

When was Medivate Partners founded?

Medivate Partners was founded in 2002.

What type of investor is Medivate Partners?

Medivate Partners is a private equity firm.

Where is Medivate Partners headquartered?

Medivate Partners is headquartered in Seoul, South Korea.

 Subscribe to unlock this and 200,514
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 192K M&A Transactions
  • 196K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.